drugset / Trial / NCT00000226
Alternate-Day Buprenorphine Administration. Phase VII - 8
Treatment
Summary
The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects under open dosing conditions.
Timeline
- Start
- 1994-11
- Primary completion
- —
- Completion
- —
Publications
- Background Patry, Bicket, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (2) A comparison of four different dosing schedules under open and choice procedures.. Patry, Bickel, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (2) A comparison of four different dosing schedules under open and choice procedures.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |